Advancing Early Detection: Affordable 7-Gene Panel for Oral Cancer Diagnosis

• Our client is a leading precision medicine diagnostics provider with a longstanding relationship with Strand since 2017.
• They required a method for early diagnosis of Oral Cavity Squamous Cell Carcinoma (OCSCC) to address its high morbidity and mortality rates and improve patient survival through early detection.
• Strand developed a cost-effective, 7-gene panel in our certified lab, saving the client from extra costs. The whole process, from design to validation, was completed within a year. This test not only meets the need for early detection of OCSCC but also aims to reduce the cost to below $100 per test, making it more affordable.